<DOC>
	<DOC>NCT00388609</DOC>
	<brief_summary>The purpose of this study is to learn if BMS-646256 can cause weight loss in men and women who are: - overweight with high blood pressure or high cholesterol or - obese The safety of this treatment will also be studied</brief_summary>
	<brief_title>Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Men and women, ages ≥18 to ≤70 years old with a Body Mass Index (BMI) ≥30 to ≤45 kg/m² OR BMI &gt;27 to &lt;30 kg/m² with hypertension and/or dyslipidemia defined as: Hypertension defined as treatment with an antihypertensive agent or mean systolic blood pressure ≥140 and ≤160 mmHg and/or diastolic blood pressure ≥ 90 and ≤ 105 mmHg Dyslipidemia defined as stable dose treatment with a statin, fibrate or ezetimibe for ≥ 6 weeks and/or triglycerides ≥ 150 and ≤ 600 mg/dL, LDL ≥ 130 and ≤ 300 mg/dL, or HDL &lt; 40 mg/dL Type 1 or 2 diabetes mellitus history of MI in the prior 6 months history of heart failure history of symptomatic arrhythmia active hepatic disease any documented muscle disease history of neurological symptoms or disease (including but not limited to tremor, ataxia, dizziness, neuropathy, or episodes of confusion, history of seizures, stroke or TIA) known history of major psychiatric conditions (e.g. schizophrenia anxiety disorder, dementia or bipolar disorder as defined by DSM IV criteria) history of depression or suicide attempt or ideation previous history of surgical procedures for weight loss (e.g., stomach stapling, bypass) uncontrolled blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>